0001209191-17-052399.txt : 20170912
0001209191-17-052399.hdr.sgml : 20170912
20170912151515
ACCESSION NUMBER: 0001209191-17-052399
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170801
FILED AS OF DATE: 20170912
DATE AS OF CHANGE: 20170912
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MOYES JAY M
CENTRAL INDEX KEY: 0001191062
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 033-80623
FILM NUMBER: 171080964
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACHIEVE LIFE SCIENCES, INC.
CENTRAL INDEX KEY: 0000949858
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 954343413
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 19820 NORTH CREEK PARKWAY
STREET 2: SUITE 201
CITY: BOTHELL
STATE: WA
ZIP: 98011
BUSINESS PHONE: 425-686-1500
MAIL ADDRESS:
STREET 1: 19820 NORTH CREEK PARKWAY
STREET 2: SUITE 201
CITY: BOTHELL
STATE: WA
ZIP: 98011
FORMER COMPANY:
FORMER CONFORMED NAME: ONCOGENEX PHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20080821
FORMER COMPANY:
FORMER CONFORMED NAME: SONUS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19950825
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2017-08-01
2017-08-03
0
0000949858
ACHIEVE LIFE SCIENCES, INC.
ACHV
0001191062
MOYES JAY M
19820 NORTH CREEK PARKWAY
SUITE 201
BOTHELL
WA
98011
1
0
0
0
Stock Option (right to buy)
2.89
2017-08-01
4
A
0
16400
0.00
A
2027-08-01
Common Stock
16400
16400
D
This amended Form 4 is filed to correct the exercise price to reflect that the grant was effective as of the issuer's first open trading window after approval of the grant. All other terms remain the same.
The options vest in monthly installments over 36 months commencing one month from August 1, 2017.
Sandra Thomson as attorney-in-fact for Jay Moyes
2017-09-12